Liver Function Test in Johor Bahru

A liver function test does not, for the most part, measure liver function. The name has been in use for decades and quietly misleads, because it invites you to read a raised number as a failing organ. What the panel mostly measures is injury and drainage — enzymes that sit inside liver cells and appear in the bloodstream when those cells are damaged, and enzymes that line the bile ducts and rise when bile cannot flow freely out of the liver. Only three components genuinely reflect what the liver is doing. Albumin, because the liver manufactures it. Bilirubin, because the liver takes it up, processes it and excretes it. And clotting, reported as prothrombin time or INR, because those factors are made in the liver. Everything else is a leak detector or a drainage gauge. That distinction carries a practical consequence. A person can have advanced liver disease with entirely normal enzymes, because a scarred liver has fewer surviving cells left to leak anything. A person can equally have enzymes many times the upper limit and a liver that will recover completely, as happens in acute hepatitis A. High numbers are not the same as poor function, and normal numbers are not the same as a healthy liver. So the useful question is never what one value means, because individual results here are close to uninterpretable in isolation. The information lives in the relationship between them — which markers are up, which are not, by how much relative to each other, and what the true function markers are doing alongside.

ALT, alanine aminotransferase, is the closest thing on the panel to a liver-specific marker. It is concentrated predominantly in liver cells, so when it appears in the blood in raised amounts, the reasonable inference is that liver cells are being damaged and spilling their contents. That is the whole of what ALT tells you. It identifies injury. It says nothing whatsoever about the cause of that injury, nothing about how long it has been going on, and nothing about whether the liver is coping. AST, aspartate aminotransferase, behaves similarly but is far less specific, because it is not confined to the liver. Substantial amounts sit in skeletal and heart muscle. A raised AST can therefore come from a hard gym session two days before the blood draw, from a long run, from a muscle strain, or from a statin-related muscle problem — none of which involve the liver at all. It is why we ask what you were doing in the days before the test. Because the two enzymes are distributed differently, comparing them is informative in a way that neither value achieves alone. In most liver conditions, including fatty liver, chronic viral hepatitis and the majority of drug reactions, ALT sits above AST. When that relationship inverts and AST exceeds ALT, particularly when it is more than roughly twice as high, two possibilities move up the list: alcohol-related liver disease, in which the pattern is characteristic, and established fibrosis or cirrhosis from any cause, in which the ratio tends to rise as scarring advances. Treat that ratio as a pointer rather than a verdict: it shifts probability without settling anything, and muscle activity or a second coexisting cause distorts it easily.

ALP, alkaline phosphatase, is the panel's marker of bile duct trouble. It concentrates in the cells lining the bile ducts and rises when bile drainage is obstructed or inflamed — by a gallstone lodged in the common bile duct, by inflammation of the ducts, by a mass compressing them, or by drugs that interfere with bile flow within the liver itself. The complication is that ALP is not exclusively hepatic. Substantial quantities come from bone, and smaller amounts from the placenta and the intestine. A raised ALP in an adolescent growth spurt is usually just active bone formation and entirely normal. In pregnancy it is often placental. In an older adult it may reflect bone disease, a healing fracture or vitamin D deficiency rather than anything hepatic. GGT, gamma-glutamyl transferase, is what resolves that ambiguity, and this is its most valuable use. GGT is present in the biliary system but not in bone. So if ALP and GGT are raised together, the source is almost certainly hepatobiliary and the next steps are directed at the liver and bile ducts. If ALP is raised while GGT is normal, attention should turn to bone, and the appropriate investigation is a different one entirely. GGT has a second, less reliable reputation. It is sensitive to alcohol and is induced by various medications including some anti-epileptics, so it does rise in regular drinkers. But sensitive is not the same as specific, and an isolated raised GGT proves nothing. It rises in fatty liver, obesity, diabetes and heart failure, in people who drink nothing at all, and it should never be treated by a patient, a relative or an employer as evidence of drinking. On its own, with an otherwise normal panel, it is one of the least alarming findings on the report.

Bilirubin is the pigment produced when red blood cells are broken down at the end of their life. It arrives at the liver unconjugated and not water soluble; the liver attaches a chemical group to it, making it soluble, then excretes it into bile. Splitting total bilirubin into those two fractions localises the problem. A predominantly unconjugated rise suggests either that red cells are being destroyed faster than usual or that the conjugating step is slow. A predominantly conjugated rise means the liver processed the bilirubin but could not get rid of it, pointing to obstructed bile flow or liver cell disease. Jaundice is what this looks like once bilirubin accumulates enough to be visible — a yellow tinge, usually seen in the whites of the eyes before the skin. Dark urine with pale stools alongside it suggests the conjugated, obstructive type and warrants prompt assessment. Gilbert's syndrome deserves attention because it causes so much needless worry. It is a common inherited variation in the enzyme that conjugates bilirubin, present in a meaningful minority of the population, and entirely harmless. It produces a mildly raised unconjugated bilirubin with normal enzymes, and the level characteristically rises when you fast, are unwell with something else, are dehydrated or are under physical stress — which is exactly the situation in which people have blood taken. It needs no treatment and no monitoring, and recognising it early spares years of repeat testing and scans. Albumin and clotting are the true function markers. Albumin is a protein the liver makes continuously, and it falls when the liver has been impaired for a sustained period, which makes it more useful in chronic disease than in acute illness. It is not liver-specific either — albumin also falls in malnutrition, in significant inflammatory illness, and when the kidneys leak protein. Prothrombin time or INR responds faster, because those clotting factors have a short lifespan, and a prolonging INR in someone with liver disease is a serious finding rather than a subtle one.

With those pieces in place, the panel resolves into three recognisable patterns, and identifying yours is the most useful single step in working out what is going on. The hepatocellular pattern is ALT and AST raised disproportionately, with ALP and GGT normal or only slightly up. This says liver cells are being injured, and the usual causes are fatty liver disease, chronic hepatitis B or C, alcohol, drug or supplement injury, autoimmune hepatitis, and inherited disorders of iron or copper handling. The cholestatic pattern is ALP and GGT raised disproportionately, the transaminases normal or mildly raised, sometimes with bilirubin rising alongside. This says bile is not draining, and the causes include gallstones in the bile duct, drug-induced cholestasis, autoimmune bile duct disease, and obstruction from a mass near the pancreas or bile duct. A mixed pattern, with both sets raised together, points to drug reactions, alcohol, or advanced disease of any cause where the distinction has blurred. The degree of elevation carries its own information, independent of the pattern. A mildly raised ALT — two or three times the upper limit, in someone who feels well — is among the commonest abnormal results in general practice, and in Malaysia it is metabolic in origin far more often than anything else. An ALT in the hundreds is a different conversation, and an ALT in the thousands is a short and urgent list: acute viral hepatitis, drug or toxin injury including paracetamol, or an ischaemic insult where the liver has been deprived of blood flow. Those need assessment without delay. For the common mild elevation, the sensible sequence is repeat testing after an interval, because a good proportion settle on their own. Alongside that goes a proper history — alcohol, every medication and supplement, weight and waist, blood pressure, diabetes, cholesterol and family history. Then targeted testing as indicated: hepatitis B and C serology, a metabolic screen covering glucose or HbA1c and lipids, iron studies, and autoimmune markers where the picture suggests them. Ultrasound completes it by showing liver texture, fat, focal lesions, gallstones and the bile ducts, and it is available here on site. Referral to a gastroenterologist or hepatologist follows when enzymes stay substantially raised, when examination or imaging suggests chronic liver disease, when viral hepatitis needs treatment decisions, or when formal fibrosis assessment is required.

Malaysia sits in an intermediate prevalence region for hepatitis B, and a meaningful share of the adult population carries the virus chronically. Most do not know. That is not carelessness — chronic hepatitis B is genuinely silent, often for decades, producing no symptoms at all until it produces cirrhosis or liver cancer, and it is a leading cause of both here. Transmission matters for how people judge their own risk. In an intermediate prevalence setting like ours, much chronic infection was acquired from mother to child around the time of birth, or from close household contact in early childhood. It has nothing to do with adult behaviour, and the assumption that hepatitis B follows from something one did is both wrong and a barrier to testing. Infection acquired in infancy is also far more likely to become chronic than infection acquired as an adult, which is why the childhood route dominates. The practical point is this: liver enzymes are frequently completely normal in a chronic carrier. A clean panel does not exclude hepatitis B and is not a screening test for it. Diagnosis requires specific serology — surface antigen to establish whether you carry it, surface antibody to establish whether you are immune. Malaysia has included hepatitis B in universal infant immunisation for decades, so Malaysians born after that programme began are usually protected. Many older adults are not. Testing is worth doing if you were born before the programme, if a family member is a carrier, if your enzymes are unexplained, or if you do not know your status. Screening changes outcomes for three reasons. Effective antiviral treatment exists for those who need it and substantially reduces the risk of progression. Carriers need lifelong surveillance for liver cancer, which is treatable when found early and rarely so when found late. And household contacts and partners can be tested and vaccinated, which stops the chain there. Hepatitis C is less common here but is now curable with a short course of modern oral antiviral treatment, so finding it is worthwhile in anyone with risk factors or unexplained enzymes. Both serologies can be arranged as part of our blood testing, and eligible Malaysians aged forty and above can access screening through PEKA B40, for which we are registered.

If your ALT is mildly raised and you feel entirely well, fatty liver disease is the most likely explanation. It is now the commonest cause of abnormal liver tests in Malaysia, and its rise has tracked the rise in obesity and type 2 diabetes. It is best understood as the liver's expression of metabolic syndrome, travelling with central obesity, insulin resistance and type 2 diabetes, raised triglycerides and hypertension. Where you find one of those you commonly find the others. One point matters locally: Asian populations develop fatty liver at a lower body mass index than European populations do, so someone whose BMI reads as acceptable can still have a significantly fatty liver. Waist measurement is often more revealing than the scale. It is almost always found by accident, on an ultrasound arranged for another reason or on a routine blood test in someone with no symptoms. Most people have simple steatosis, fat without much inflammation, which follows a benign course over many years. A subset progress to steatohepatitis, where inflammation drives scarring, and from there to fibrosis and in some cases cirrhosis and liver cancer. Separating the two groups is why some people need specialist fibrosis assessment and most do not. Fatty liver is also a marker of cardiovascular risk in its own right, which is regularly overlooked — people with fatty liver are more likely to die of heart disease than of liver disease. The abnormal ALT is therefore a reason to check blood pressure, glucose and lipids properly, not merely to watch the liver. No drug cures it, and what works instead is unglamorous and well evidenced. Losing a modest percentage of body weight reduces liver fat measurably, and losing more reduces inflammation and can improve fibrosis. Cutting sugar, and sweetened drinks above all, has a disproportionate effect, because fructose is handled by the liver and converted to fat there. Reducing refined carbohydrate — white rice portions, bread, noodles and sweet kuih — matters more than cutting dietary fat. Regular physical activity improves liver fat even when weight does not change much, which is worth knowing when the scale stalls. Ultrasound is available here, is the usual first step in assessing liver fat, texture and focal lesions, and can be arranged alongside blood testing in one visit. Call +60 7-251 1162 or WhatsApp +60 17-500 7205 if you have a result you would like properly worked up rather than repeated indefinitely.

Alcohol is a direct hepatotoxin, and the relationship between intake and liver injury is dose-dependent and cumulative over years. That is a factual statement rather than a moral one, and nothing useful comes of a consultation in which intake is understated to avoid disapproval. Susceptibility varies, women develop injury at lower intakes than men, and drinking on top of another liver condition compounds the damage. Paracetamol is safe at recommended doses and a genuine cause of acute liver failure in overdose — and the risk is not confined to deliberate overdose. People take a paracetamol tablet, then a combination cold and flu preparation, then a sachet for a headache, without realising that several of those contain paracetamol. Doses stack silently. Read the ingredients of every cold, flu and pain preparation you take, and do not exceed the stated daily maximum. Several prescribed medicines can affect the liver, including certain antibiotics, anti-tuberculosis therapy, some anti-epileptic drugs, methotrexate and anabolic steroids. That is not a reason to stop one on the strength of a result — some elevations are expected, monitored and acceptable, and stopping tuberculosis treatment unilaterally is dangerous. It means the medicine list is part of the assessment. Herbal, traditional and supplement products deserve their own emphasis, because they are the exposure people most reliably fail to mention. Natural does not mean safe for the liver. Herbal slimming and detox preparations, unregistered traditional remedies, high-dose bodybuilding supplements and concentrated green tea extract have all caused serious liver injury, including cases requiring transplantation. Adulteration of unregistered products with undeclared pharmaceutical ingredients is a documented problem here, so what is on the label may not be what is in the capsule. Include everything when we ask: jamu, imported supplements, protein powders, high-dose vitamins, slimming teas, and anything a friend or an online seller recommended. Bringing the bottles beats recalling the names. Some symptoms need urgent attention rather than an appointment. Go to the nearest emergency department or call 999 for yellowing of the eyes or skin, dark urine with pale stools, severe abdominal pain, vomiting of blood, black tarry stools, confusion or unusual drowsiness, or significant swelling of the abdomen. Any suspected paracetamol overdose is an emergency regardless of how well the person feels, because the treatment window is early and the symptoms appear late. For everything else, Klinik Muhibbah is at No. 62 Jalan Kiambang, Taman Bunga Raya, 81700 Masai, Johor, with Dr. Prabagaran Kanapathy and Dr. Kirubah Sai Patnaik seeing patients Monday to Thursday and Saturday 9AM to 9PM, Friday 9AM to 3PM and Sunday 9AM to 1PM. Book at movo-x.com/kiosk/muhibbah, and ask what a test or scan costs when you call. An abnormal liver result is best read alongside your history and examination rather than on its own.